ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.

Revenue
+5.93%
EPS
+23.1%
Free cash flow
−9.79%
Total debt
−38.9%

Quarter to September 2026, against a year earlier

232.28 7.03 −2.94%
Market cap
$33.7B
P/E
21.7×
Fwd P/E
19.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

7 7 6 8
ROE
25.68% 25.25% 24.27% 26.40%
ROA
19.00% 18.59% 17.77% 19.29%
ROIC
21.42% 22.59% 21.38% 22.81%
Return on Tangible Assets
47.40% 46.33% 43.38% 57.17%
Average Days of Receivables
66.64 65.83 66.90 61.92
Free Cash Flow per Share
12.18 11.95 11.19 11.11
Free Cash Flow
1,776.59 1,736.26 1,628.66 1,588.36
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026